VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)

Last updated: January 6, 2026
Sponsor: Columbia University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Drug Use

Treatment

VibraCool mechanical stimulation and neuromodulatory therapeutic device

Standard ice packs

Cryocompression (Game Ready, Bregs) device

Clinical Study ID

NCT06456268
AAAU3696
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this project is to test the effects of the VibraCool mechanical stimulation neuromodulatory therapeutic device on post-operative pain and opioid use following anterior crucitate ligament reconstruction (ACLR), and thus residual opioids in circulation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Underwent ACL reconstruction

Exclusion

Exclusion Criteria:

  • Pediatric iliotibial band ACL reconstruction (known to cause significantly morepain)

  • Non-english speakers (limitations of our study group)

Study Design

Total Participants: 130
Treatment Group(s): 4
Primary Treatment: VibraCool mechanical stimulation and neuromodulatory therapeutic device
Phase:
Study Start date:
June 01, 2026
Estimated Completion Date:
November 30, 2026

Connect with a study center

  • Columbia University Medical Center

    New York, New York 10032
    United States

    Site Not Available

  • Columbia University Medical Center

    New York 5128581, New York 5128638 10032
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.